help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, R. T.
Right arrow Articles by DeGroot, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, R. T.
Right arrow Articles by DeGroot, L. J.

Molecular Endocrinology, Vol 9, 86-95, Copyright © 1995 by Endocrine Society


ARTICLES

The dominant negative effect of thyroid hormone receptor splicing variant alpha 2 does not require binding to a thyroid response element

RT Liu, S Suzuki, T Miyamoto, T Takeda, M Ozata and LJ DeGroot
Department of Medicine, University of Chicago, Illinois 60637, USA.

The functionally inactive thyroid hormone receptor splicing variant- alpha 2 (TRv alpha 2) can inhibit transcriptional activation by TR alpha 1 or beta 1, demonstrating a dominant negative effect (DNE). We examine here the three commonly proposed mechanisms, namely, competition for binding to thyroid hormone response elements (TREs), formation of inactive heterodimers, and squelching. A mutation introduced into the DNA-binding domain (DBD) of the TRv alpha 2 was designed to prevent its binding to TREs. In transient cotransfection studies, the DBD mutant has nearly the same DNE as does TRv alpha 2 on three different TRE-containing reporter genes. The DNE of TRv alpha 2 is also not reversed by cotransfection with excess retinoid X receptor- alpha. Extracts of COS cells cotransfected with TR alpha 1 and either TRv alpha 2 or DBD mutant at different ratios were analyzed by gel shift assays. Neither TRv alpha 2 or the mutant altered binding of TR alpha 1 to four radiolabeled TREs. TRv alpha 2 itself can inhibit constitutive transactivation by a thymidine kinase promoter-driven reporter construct. Our results suggest that TRv alpha 2 can function in a dominant negative manner without binding to a TRE, at least for certain TREs. It is concluded that the DNE of TRv alpha 2 may occur through another unrecognized mechanism, perhaps by binding to basal transcription factors.


This article has been cited by other articles:


Home page
EndocrinologyHome page
E. R. Nelson and H. R. Habibi
Functional Significance of a Truncated Thyroid Receptor Subtype Lacking a Hormone-Binding Domain in Goldfish
Endocrinology, September 1, 2008; 149(9): 4702 - 4709.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C R Liu, L Y Li, F Shi, X Y Zang, Y M Liu, Y Sun, and B H Kan
Effects of hyper- and hypothyroid on expression of thyroid hormone receptor mRNA in rat myocardium
J. Endocrinol., December 1, 2007; 195(3): 429 - 438.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J Kwakkel, W M Wiersinga, and A Boelen
Interleukin-1{beta} modulates endogenous thyroid hormone receptor {alpha} gene transcription in liver cells
J. Endocrinol., August 1, 2007; 194(2): 257 - 265.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Ng, A. Rusch, L. L. Amma, K. Nordstrom, L. C. Erway, B. Vennstrom, and D. Forrest
Suppression of the deafness and thyroid dysfunction in Thrb-null mice by an independent mutation in the Thra thyroid hormone receptor {alpha} gene
Hum. Mol. Genet., November 1, 2001; 10(23): 2701 - 2708.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Oberste-Berghaus, K. Zanger, K. Hashimoto, R. N. Cohen, A. N. Hollenberg, and F. E. Wondisford
Thyroid Hormone-independent Interaction between the Thyroid Hormone Receptor beta 2 Amino Terminus and Coactivators
J. Biol. Chem., January 21, 2000; 275(3): 1787 - 1792.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. P. Farwell and S. A. Dubord-Tomasetti
Thyroid Hormone Regulates the Extracellular Organization of Laminin on Astrocytes
Endocrinology, November 1, 1999; 140(11): 5014 - 5021.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
A. P. Farwell and S. A. Dubord-Tomasetti
Thyroid Hormone Regulates the Expression of Laminin in the Developing Rat Cerebellum
Endocrinology, September 1, 1999; 140(9): 4221 - 4227.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
T. Tagami, P. Kopp, W. Johnson, O. K. Arseven, and J. L. Jameson
The Thyroid Hormone Receptor Variant {alpha}2 Is a Weak Antagonist because It Is Deficient in Interactions with Nuclear Receptor Corepressors
Endocrinology, May 1, 1998; 139(5): 2535 - 2544.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Farsetti, J. Lazar, M. Phyillaier, R. Lippoldt, A. Pontecorvi, and V. M. Nikodem
Active Repression by Thyroid Hormone Receptor Splicing Variant {alpha}2 Requires Specific Regulatory Elements in the Context of Native Triiodothyronine-Regulated Gene Promoters
Endocrinology, November 1, 1997; 138(11): 4705 - 4712.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-F. Langlois, K. Zanger, T. Monden, J. D. Safer, A. N. Hollenberg, and F. E. Wondisford
A Unique Role of the beta -2 Thyroid Hormone Receptor Isoform in Negative Regulation by Thyroid Hormone. MAPPING OF A NOVEL AMINO-TERMINAL DOMAIN IMPORTANT FOR LIGAND-INDEPENDENT ACTIVATION
J. Biol. Chem., October 3, 1997; 272(40): 24927 - 24933.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
O. Chassande, A. Fraichard, K. Gauthier, F. Flamant, C. Legrand, P. Savatier, V. Laudet, and J. Samarut
Identification of Transcripts Initiated from an Internal Promoter in the c-erbA{alpha} Locus That Encode Inhibitors of Retinoic Acid Receptor-{alpha} and Triiodothyronine Receptor Activities
Mol. Endocrinol., August 1, 1997; 11(9): 1278 - 1290.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. J. Reginato, J. Zhang, and M. A. Lazar
DNA-independent and DNA-dependent Mechanisms Regulate the Differential Heterodimerization of the Isoforms of the Thyroid Hormone Receptor with Retinoid X Receptor
J. Biol. Chem., November 8, 1996; 271(45): 28199 - 28205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-Z. Yang, M. Burgos-Trinidad, Y. Wu, and R. J. Koenig
Thyroid Hormone Receptor Variant alpha 2. ROLE OF THE NINTH HEPTAD IN DNA BINDING, HETERODIMERIZATION WITH RETINOID X RECEPTORS, AND DOMINANT NEGATIVE ACTIVITY
J. Biol. Chem., November 8, 1996; 271(45): 28235 - 28242.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. M. Yen, Y. Liu, A. Sugawara, and W. W. Chin
Vitamin D Receptors Repress Basal Transcription and Exert Dominant Negative Activity on Triiodothyronine-mediated Transcriptional Activity
J. Biol. Chem., May 3, 1996; 271(18): 10910 - 10916.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society